Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07176026

Follow-Up of Ureteral Stones ≤4 mm

Follow-Up of Ureteral Stones ≤4 mm: Evaluate the Proportion of Spontaneous Passage and Assess if Symptoms and Stone Characteristics Can Predict Stone Passage

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
1,600 (estimated)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate the proportion of ureteral stones ≤4 mm that pass spontaneously within 4 and 8 weeks and assess if pain, blood test (S-creatinine), stone size, stone location and hydronephrosis can predict stone passage. The participants will be asked to fill in a questionare regarding symptoms, give a blood test and undergo a follow-up computed tomography.

Detailed description

All patients with a diagnosis of ureteral stone ≤4 mm at the Emergency Department in Helsingborg will be asked to participate. If they give consent data regarding age, gender, stone size, stone location, hydronephrosis, S-creatinine, treatments and results from the follow up CT is extraced from the medical records.

Conditions

Timeline

Start date
2025-02-01
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2025-09-16
Last updated
2025-09-16

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT07176026. Inclusion in this directory is not an endorsement.

Follow-Up of Ureteral Stones ≤4 mm (NCT07176026) · Clinical Trials Directory